BRIEF-Biogen and Abbvie receive positive opinion from the CHMP on zinbryta By: Reuters: Company News April 29, 2016 at 08:03 AM EDT * Biogen and abbvie receive positive opinion from the chmp on zinbryta(tm) (daclizumab) for treatment of multiple sclerosis Read More >> Related Stocks: AbbVie Biogen Idec